165 related articles for article (PubMed ID: 3140683)
1. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection.
King CH; Lombardi G; Lombardi C; Greenblatt R; Hodder S; Kinyanjui H; Ouma J; Odiambo O; Bryan PJ; Muruka J
Am J Trop Med Hyg; 1988 Sep; 39(3):295-305. PubMed ID: 3140683
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity.
King CH; Lombardi G; Lombardi C; Greenblatt R; Hodder S; Kinyanjui H; Ouma J; Odiambo O; Bryan PJ; Muruka J
Am J Trop Med Hyg; 1990 Jun; 42(6):587-95. PubMed ID: 2115308
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya.
King CH; Muchiri E; Ouma JH; Koech D
Am J Trop Med Hyg; 1991 Oct; 45(4):498-508. PubMed ID: 1951859
[TBL] [Abstract][Full Text] [Related]
4. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.
King CH; Muchiri EM; Ouma JH
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():203-10. PubMed ID: 1343896
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of metrifonate in a highly endemic area of urinary schistosomiasis in Kenya.
Sato K; Shimada M; Noda S; Muhoho ND; Katsumata T; Sato A; Aoki Y
Am J Trop Med Hyg; 1988 Jan; 38(1):81-5. PubMed ID: 3124647
[TBL] [Abstract][Full Text] [Related]
6. Dose-finding study for praziquantel therapy of Schistosoma haematobium in Coast Province, Kenya.
King CH; Wiper DW; De Stigter KV; Peters PA; Koech D; Ouma JH; Arap Siongok TK; Mahmoud AA
Am J Trop Med Hyg; 1989 May; 40(5):507-13. PubMed ID: 2499203
[TBL] [Abstract][Full Text] [Related]
7. Single dose metrifonate or praziquantel treatment in Kenyan children. I. Effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly.
Stephenson LS; Kinoti SN; Latham MC; Kurz KM; Kyobe J
Am J Trop Med Hyg; 1989 Oct; 41(4):436-44. PubMed ID: 2508501
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
[TBL] [Abstract][Full Text] [Related]
9. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin).
Delegue P; Picquet M; Shaw DJ; Vercruysse J; Sambou B; Ly A
Ann Trop Med Parasitol; 1998 Oct; 92(7):775-83. PubMed ID: 9924535
[TBL] [Abstract][Full Text] [Related]
10. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya.
King CH; Keating CE; Muruka JF; Ouma JH; Houser H; Siongok TK; Mahmoud AA
Am J Trop Med Hyg; 1988 Oct; 39(4):361-8. PubMed ID: 3142286
[TBL] [Abstract][Full Text] [Related]
11. Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia.
Wilkins HA; Moore PJ
J Trop Med Hyg; 1987 Apr; 90(2):83-92. PubMed ID: 3104624
[TBL] [Abstract][Full Text] [Related]
12. The effect of metrifonate in mixed Schistosoma haematobium and Schistosoma mansoni infections in humans.
Doehring E; Poggensee U; Feldmeier H
Am J Trop Med Hyg; 1986 Mar; 35(2):323-9. PubMed ID: 3082230
[TBL] [Abstract][Full Text] [Related]
13. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
[TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
Barda B; Coulibaly JT; Hatz C; Keiser J
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection.
Feldmeier H; Chitsulo L
Arzneimittelforschung; 1999 Jul; 49(7):557-65. PubMed ID: 10442201
[TBL] [Abstract][Full Text] [Related]
17. Single dose metrifonate or praziquantel treatment in Kenyan children. II. Effects on growth in relation to Schistosoma haematobium and hookworm egg counts.
Stephenson LS; Latham MC; Kurz KM; Kinoti SN
Am J Trop Med Hyg; 1989 Oct; 41(4):445-53. PubMed ID: 2508502
[TBL] [Abstract][Full Text] [Related]
18. Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections.
Latham MC; Stephenson LS; Kurz KM; Kinoti SN
Am J Trop Med Hyg; 1990 Aug; 43(2):170-9. PubMed ID: 2117858
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.
El-Khoby T; Galal N; Fenwick A; Barakat R; El-Hawey A; Nooman Z; Habib M; Abdel-Wahab F; Gabr NS; Hammam HM; Hussein MH; Mikhail NN; Cline BL; Strickland GT
Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):88-99. PubMed ID: 10813505
[TBL] [Abstract][Full Text] [Related]
20. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
